137 related articles for article (PubMed ID: 38644522)
21. The association between hidradenitis suppurativa and male and female infertility: A population-based study.
Tzur Bitan D; Kridin K; Hodak E; Cohen A; Sherman S
Australas J Dermatol; 2021 May; 62(2):e223-e227. PubMed ID: 33399222
[TBL] [Abstract][Full Text] [Related]
22. The impact of hidradenitis suppurativa on general health is higher than that of hypertension, congestive heart failure, type 2 diabetes, myocardial infarction and depression.
Sampogna F; Fania L; Mazzanti C; Pallotta S; Panebianco A; Mastroeni S; Didona B; Abeni D
J Eur Acad Dermatol Venereol; 2020 Aug; 34(8):e386-e388. PubMed ID: 32043666
[No Abstract] [Full Text] [Related]
23. Comparative Overall Comorbidity Burden Among Patients With Hidradenitis Suppurativa.
Reddy S; Strunk A; Garg A
JAMA Dermatol; 2019 Jul; 155(7):797-802. PubMed ID: 30994865
[TBL] [Abstract][Full Text] [Related]
24. Epidemiology and comorbidity of hidradenitis suppurativa in Korea for 17 years: A nationwide population-based cohort study.
Lee JW; Heo YW; Lee JH; Lee S
J Dermatol; 2023 Jun; 50(6):778-786. PubMed ID: 36806098
[TBL] [Abstract][Full Text] [Related]
25. Assessment of subclinical atherosclerosis in hidradenitis suppurativa.
Pascual JC; González I; Corona D; Hispán P; Ramos JM; Sánchez-Paya J; Jemec GB
J Eur Acad Dermatol Venereol; 2017 Jul; 31(7):1229-1238. PubMed ID: 27911007
[TBL] [Abstract][Full Text] [Related]
26. Psoriasis and hidradenitis suppurativa: A large-scale population-based study.
Kridin K; Shani M; Schonmann Y; Fisher S; Shalom G; Comaneshter D; Batat E; Cohen AD
J Am Acad Dermatol; 2023 May; 88(5):e231-e236. PubMed ID: 30502412
[TBL] [Abstract][Full Text] [Related]
27. Long-term risk of death in patients with hidradenitis suppurativa.
Kohorst JJ; Ghanavatian S; Davis MDP; Weaver AL; Schleck CD; Swanson DL
Int J Dermatol; 2023 May; 62(5):631-636. PubMed ID: 36097962
[TBL] [Abstract][Full Text] [Related]
28. A history of asthma is associated with susceptibility to hidradenitis suppurativa: a population-based longitudinal study.
Kridin K; Shihade W; Weinstein O; Zoller L; Onn E; Cohen A; Solomon-Cohen E
Arch Dermatol Res; 2023 Dec; 315(10):2845-2851. PubMed ID: 37642698
[TBL] [Abstract][Full Text] [Related]
29. Risk of psoriasis in people with hidradenitis suppurativa: A systematic review and meta-analysis.
Gau SY; Preclaro IAC; Wei JC; Lee CY; Kuan YH; Hsiao YP; Juang SE; Ma KS
Front Immunol; 2022; 13():1033844. PubMed ID: 36532043
[TBL] [Abstract][Full Text] [Related]
30. Hidradenitis suppurativa and diabetes mellitus: updated systematic review and adjusted meta-analysis.
Phan K; Charlton O; Smith SD
Clin Exp Dermatol; 2019 Jun; 44(4):e126-e132. PubMed ID: 30730068
[TBL] [Abstract][Full Text] [Related]
31. Decreased Arterial Vascular Tone in Small Arteries in Severe Hidradenitis Suppurativa - A Study Using Finger Photopulseplethysmography.
Miller IM; Ahlehoff O; Zarchi K; Rytgaard H; Mogensen UB; Ellervik C; E Jemec GB
Acta Dermatovenerol Croat; 2022 Sep; 30(2):119-122. PubMed ID: 36254547
[TBL] [Abstract][Full Text] [Related]
32. Serum IL-36α, IL-36β, and IL-36γ levels in patients with hidradenitis suppurativa: association with disease characteristics, smoking, obesity, and metabolic syndrome.
Hayran Y; Allı N; Yücel Ç; Akdoğan N; Turhan T
Arch Dermatol Res; 2020 Apr; 312(3):187-196. PubMed ID: 31722038
[TBL] [Abstract][Full Text] [Related]
33. New-onset depression among children, adolescents, and adults with hidradenitis suppurativa.
Wright S; Strunk A; Garg A
J Am Acad Dermatol; 2020 Nov; 83(5):1360-1366. PubMed ID: 32446831
[TBL] [Abstract][Full Text] [Related]
34. Visfatin and insulin levels and cigarette smoking are independent risk factors for hidradenitis suppurativa: a case-control study.
Akdogan N; Alli N; Uysal PI; Topcuoglu C; Candar T; Turhan T
Arch Dermatol Res; 2018 Dec; 310(10):785-793. PubMed ID: 30293125
[TBL] [Abstract][Full Text] [Related]
35. Serum high-sensitivity C-reactive protein, tumor necrosis factor-α, interleukin (IL)-1β, IL-17A and IL-23 levels in patients with hidradenitis suppurativa.
Saraç Öztürk G; Ergun T; Peker Eyüboğlu İ; Akkiprik M
Cytokine; 2021 Aug; 144():155585. PubMed ID: 34034145
[TBL] [Abstract][Full Text] [Related]
36. Prevalence and association of polycystic ovary syndrome and hidradenitis suppurativa in underrepresented groups.
Ch'en PY; Toker M; Chen G; Hosgood HD; Campton KL; Cohen SR
Arch Dermatol Res; 2024 Jun; 316(7):379. PubMed ID: 38850290
[TBL] [Abstract][Full Text] [Related]
37. Exploring the role of systemic immune-inflammation index and neutrophil-lymphocyte ratio in cardiovascular risk stratification for patients with hidradenitis suppurativa: A cross-sectional study.
Sánchez-Díaz M; Salvador-Rodríguez L; Cuenca-Barrales C; Arias-Santiago S; Molina-Leyva A
J Dermatol; 2022 Dec; 49(12):1238-1244. PubMed ID: 36000267
[TBL] [Abstract][Full Text] [Related]
38. Demographic and clinical features of hidradenitis suppurativa in Korea.
Yang JH; Moon J; Kye YC; Kim KJ; Kim MN; Ro YS; Park MY; Ahn HH; Lee MW; Lee WJ; Lee JH; Lee JB; Jang MS; Choi YS; Choi YW; Suh DH;
J Dermatol; 2018 Dec; 45(12):1389-1395. PubMed ID: 30294846
[TBL] [Abstract][Full Text] [Related]
39. Comorbidity screening in hidradenitis suppurativa: Evidence-based recommendations from the US and Canadian Hidradenitis Suppurativa Foundations.
Garg A; Malviya N; Strunk A; Wright S; Alavi A; Alhusayen R; Alikhan A; Daveluy SD; Delorme I; Goldfarb N; Gulliver W; Hamzavi I; Jaleel T; Kimball AB; Kirby JS; Kirchhof MG; Lester J; Lev-Tov H; Lowes MA; Micheletti R; Orenstein LA; Piguet V; Sayed C; Tan J; Naik HB
J Am Acad Dermatol; 2022 May; 86(5):1092-1101. PubMed ID: 33493574
[TBL] [Abstract][Full Text] [Related]
40. Hidradenitis suppurativa and social disadvantage: A nationwide administrative data study of the French hospitalized population.
Bulsei J; Fontas E; Passeron T
J Eur Acad Dermatol Venereol; 2023 Sep; 37(9):1914-1919. PubMed ID: 37147873
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
